Skip to main content

18 October 2016

Smiths Group plc (“the Company”) announces today that it has established a €2.5 billion Euro Medium Term Note Programme (“the EMTN programme”) with its ten relationship banks as dealers.

The EMTN programme will facilitate the issuance by the Company of senior notes over time in various currencies and maturities as a continuing element of its financing strategy. Notes issued under the EMTN programme will be guaranteed by Smiths Group International Holdings Limited and will rank pari passu with all of the Company’s outstanding senior notes and other debt obligations.

Chris O’Shea, Chief Financial Officer, said:

“This programme underpins Smiths Group’s existing strategy to finance our balance sheet from the rated public debt markets. It provides us with increased flexibility in refinancing our debt maturities over the next two years, and in financing portfolio management activities, such as the agreement we announced in April to acquire Morpho Detection.”

A base prospectus dated 17 October 2016 relating to the establishment of the EMTN programme (“the Prospectus”) has been approved by the UK Listing Authority and is available for viewing.

To view the Prospectus, please click here.

The Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

Related articles

Interconnect Connector

Smiths Interconnect launches new technology to improve connectivity in mission critical applications

Read our latest company news as Smiths Interconnect launches new connector technology

Find out more Call to action arrow icon
Ariane 6

Smiths Group supports launch of Ariane 6 space rocket

Read our latest company news as Smiths Group supports the launch of the Ariane 6 space rocket

Find out more Call to action arrow icon
Smiths Detection HI SCAN 6040 Ctix

Smiths Detection Selected by Zurich Airport to Trial Advances CT X-Ray Scanners

Read our latest company news as Smiths Detection is selected by by Zurich Airport to Trial Advances CT X-Ray Scanners.

Find out more Call to action arrow icon
Sign up for updates Call to action arrow icon